Cleared Traditional

K222332 - MeMed BV (FDA 510(k) Clearance)

Mar 2023
Decision
233d
Days
Class 2
Risk

K222332 is an FDA 510(k) clearance for the MeMed BV. This device is classified as a Immunoassay For Host Biomarkers Of Infection (Class II - Special Controls, product code QPS).

Submitted by MeMed Diagnostics, Ltd. (Tirat Carmel, IL). The FDA issued a Cleared decision on March 23, 2023, 233 days after receiving the submission on August 2, 2022.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3215. A Semi-quantitative Immunoassay That Quantifies The Relative Levels Of Host Response Proteins Isolated From Serum Or Similar Specimens..

Submission Details

510(k) Number K222332 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2022
Decision Date March 23, 2023
Days to Decision 233 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code QPS - Immunoassay For Host Biomarkers Of Infection
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3215
Definition A Semi-quantitative Immunoassay That Quantifies The Relative Levels Of Host Response Proteins Isolated From Serum Or Similar Specimens.